Mohammed is a pharmacist with an M.Sc. in Drug Development with Bio-Business (Distinction) and a Doctorate in Antibody Engineering from the University of Aberdeen, followed by an Executive MBA. He has worked across biotech and pharmaceutical organisations, including ImmunoSolv, Scotia Biologics, and National Pharmaceutical Industries. Mohammed is also the founder of SiMologics, a University of Strathclyde-based biotech start-up.

Following postdoctoral work at the University of Aberdeen, he joined the University of Strathclyde in 2016, supporting academic-industry collaborations as a researcher and impact champion. In 2021, he joined CMAC as Project and Industrial Translation Manager for the £5m UKRI Made Smarter Innovation programme, the Digital Medicines Manufacturing Research Centre (DM²), leading the delivery across three universities and a consortium of 30+ pharma and technology partners to accelerate adoption of digital technologies in medicines manufacturing.